Product Information

PREGABALIN 300 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0695 per EA under NDC 65862076590. Its NADAC has been published 145 times since Feb 14, 2024.

FDA first approved this application on Mar 29, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PREGABALIN 300 MG CAPSULE

Pregabalin
$0.0695per EA
DEA Schedule CV

Strength

300 mg/1

NDC

65862076590

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA205321

FDA Approved

3/29/2023

TE Code

AB

On Market Since

3/29/2023

Price Statistics

The NADAC for PREGABALIN 300 MG CAPSULE has been published 145 times since Feb 14, 2024, and over the history we have for it it has declined 20.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0695 per EA
All-time high$0.0906 (Oct 16, 2024)
All-time low$0.0628 (Nov 20, 2024)
52-week high$0.0698
52-week low$0.0644
Median price$0.0713
Average price$0.0740
Largest weekly change+30.8% (Aug 21, 2024)
Weeks tracked145
Tracking sinceFeb 14, 2024

Price History

1W

+0.8%

1M

+4.5%

3M

+8.0%

6M

+6.6%

1Y

-0.4%

3Y

N/A

5Y

N/A

All

-20.6%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PREGABALIN 300 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 300 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.0695 per EA (NDC 65862076590), effective Nov 18, 2026.

How has the price of PREGABALIN 300 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PREGABALIN 300 MG CAPSULE has declined 20.6%. It has been tracked across 145 weekly CMS publications since Feb 14, 2024.

What are the highest and lowest recorded NADAC prices for PREGABALIN 300 MG CAPSULE?

Since Feb 14, 2024, the NADAC for PREGABALIN 300 MG CAPSULE has ranged from a low of $0.0628 (Nov 20, 2024) to a high of $0.0906 (Oct 16, 2024), with a median of $0.0713 per EA.

Are there cheaper alternatives to PREGABALIN 300 MG CAPSULE?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 300 MG CAPSULE, is $0.0669 per EA — about 4% below PREGABALIN 300 MG CAPSULE.

Who manufactures PREGABALIN 300 MG CAPSULE?

PREGABALIN 300 MG CAPSULE (NDC 65862076590) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.